Faculty of Medicine Ain Shams University
Cairo, Abbassia, 11591, Egypt
NCT Number: NCT06847594
The goal of this clinical trial is to learn if Dextrose 10% or superhydration works to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
. The main questions it aims to answer are:
Does Dextrose 10% or superhydration lower the number of times participants gets an episode of nausea and vomititng after laparoscopic cholecystectomy surgery? Researchers will compare Dextrose 10% versus superhydration to a placebo (a look-alike substance that contains no drug) to see if glucose 10% or superhydation can work to prevent postoperative nausea and vomiting.
Participants will:
Take Dextrose 10% or superhydration or a placebo in the operation monitored for 4 hours after surgery to check on their nausea and vomiting state
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Phase 3
Cairo, Abbassia, 11591, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ringer lactate 20 ml/kg over the first 90 to 120 minutes after induction intraoperatively
Other names: Superhydration
Dextrose 10% 250 ml over 60 minutes
Time frame: Postoperative 4 hours stay in PACU
Time frame: Postoperative 4 hours stay in PACU
Time frame: Postoperative 4 hours stay in PACU
Severity of PONV was assessed using a 4-point Verbal Descriptive Scale (VDS) which consists of:
Score 0= no PONV: no complaint of nausea or vomiting; Score 1= mild PONV: patient complains from nausea but doesn't need antiemetic treatment.
Score 2= moderate PONV: patient complains from nausea and need antiemetic treatment; Score 3= severe PONV: patient complains from nausea with episode of vomiting requiring antiemetic treatment.
PONV scores were obtained every half hour
Time frame: From the moment of extubation till the moment of discharge from PACU with patient being completely vitally stable and nausea and vomiting free , assessed to be from 4 to 8 hours
Time frame: Postoperative period 4 hours stay in PACU. ( if the patient needed to stay for longer duration in the PACU for any medical reason then any antiemetic used in this period will be recorded as well )
Severity of PONV was assessed using a 4-point Verbal Descriptive Scale (VDS) which consists of:
Score 0= no PONV: no complaint of nausea or vomiting; Score 1= mild PONV: patient complains from nausea but doesn't need antiemetic treatment.
Score 2= moderate PONV: patient complains from nausea and need antiemetic treatment; Score 3= severe PONV: patient complains from nausea with episode of vomiting requiring antiemetic treatment.
PONV scores were obtained every half hour, Rescue antiemetic granisetron 1 mg IV was given when VDS scores were 2 or more. Medications were given only after excluding other causes of PONV such as hypovolemia, hypotension, hypoxia. The total number of doses of antiemetics used were obtained every half hour from the time of entry to the PACU for 4 hours
Ain Shams University
Other
Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (Prospective Randomised Controlled Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06886230
Nausea, Pathologic Processes
Islamabad, Capital, Pakistan
View Trial DetailsNCT01474915
Nausea, Pathologic Processes
Columbus, Ohio, United States
View Trial DetailsNCT07315412
Intraperitoneal Chemotherapy, Nausea
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07201883
Nausea, Pathologic Processes
Beirut, Lebanon
View Trial Details